Renal potassium handling in healthy and sick newborns

Hao Zhou1, Lisa M Satlin

  • 1Division of Neonatology, Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.

Insights

Neonatal kidneys retain potassium (K+) due to lower K+ secretion in the cortical collecting duct (CCD). This involves fewer K+ channels and more absorption, impacting infant K+ balance.

Area of Science:

  • Renal physiology
  • Neonatal adaptation
  • Ion transport

Background:

  • Growing infants require positive potassium (K+) balance, primarily regulated by the kidneys.
  • The distal nephron plays a crucial role in early-life K+ retention.
  • The cortical collecting duct (CCD) is key for adult renal K+ regulation, balancing secretion and absorption.

Purpose of the Study:

  • To investigate the mechanisms underlying K+ retention in the neonatal kidney.
  • To understand the role of the cortical collecting duct (CCD) in neonatal K+ homeostasis.
  • To identify factors contributing to the low K+ secretory capacity of the neonatal CCD.

Main Methods:

  • Analysis of K+ transport fluxes in the neonatal cortical collecting duct (CCD).
  • Evaluation of conducting K+ channel presence in the urinary membrane of neonatal CCD.
  • Assessment of K+ absorption rates in the neonatal CCD under in vivo conditions.

Main Results:

  • The neonatal cortical collecting duct (CCD) exhibits a low capacity for K+ secretion.
  • A relative deficiency of conducting K+ channels in the urinary membrane contributes to reduced neonatal K+ secretion.
  • Enhanced K+ absorption in the neonatal CCD further limits net urinary K+ secretion.

Conclusions:

  • The neonatal kidney's capacity for K+ retention is significantly influenced by the cortical collecting duct's (CCD) transport characteristics.
  • Reduced K+ secretion, due to fewer K+ channels, and increased absorption in the neonatal CCD contribute to positive K+ balance.
  • These findings highlight the specialized adaptations of the neonatal renal system for managing K+ homeostasis during early development.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...